CD274 and melanoma: This may be the case if the follow-up of PBMC is performed too early after the initial exposure of patients to BCG, as in the melanoma group described in Figure 4, where almost all patients (five out of six) showed a higher growth rate of PD-L1 than PD-1 PBMCs.